Garwin Gerstein & Fisher
Recent News About Garwin Gerstein & Fisher
-
Impax to pay $145M to settle Opana drug market manipulation claims from pharmacies, other direct purchasers
The lawsuit accused Impax Labs of agreeing with drugmaker Endo Pharmaceuticals to delay the entry of its Opana generic equivalent. The deal came quickly after a jury found in favor of Endo on the antitrust claims